In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Cancer Clinical Trials - COG-ALTE07C1
Protocol Summary
- Protocol No
- COG-ALTE07C1
- Principal Investigator
- Kristin Bingen
- Phase
- N/A
- Title
- Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer
- Associated Disease(s)
-
Late Effects and Supportive Studies
- Description (Summary)
- The overall goal of this study is to learn about the neuropsychological (for example,
thinking, learning, and remembering) and behavioral functioning of children being
treated for cancer. Eligible patients must currently be enrolled or plan to be enrolled on a COG therapeutic study that aims to examine neuropsychological, social, emotional, and/or behavioral functioning.
- Participating Institutions
- Childrens Hospital of Wisconsin
- ClinicalTrials.gov
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
